Paloxiron 0.075 mg/1.5 ml (IV Injection)
1.5 ml ampoule: ৳ 75.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Palonosetron |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV)
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV)
Pharmacology
- 5-HT3 receptor antagonist
- Binding affinity for 5-HT3 receptor
- Chemotherapy-induced mechanism of action
- Radiotherapy-induced mechanism of action
- Postoperative nausea and vomiting mechanism of action
- Metabolism and excretion details
Dosage & Administration
- Usual adult tablet dosage
- Usual adult IV dosage
- Chemotherapy-induced nausea and vomiting dosage
- Radiotherapy-induced nausea and vomiting dosage
- Post-operative nausea and vomiting dosage
- Children dosage
Interaction
- Safe administration with certain drugs
- No inhibition of antitumor activity
- No significant pharmacokinetic interactions
- Inhibition or induction of CYP enzymes
Contraindications
- Hypersensitivity to the drug or its components
Side Effects
- Common adverse reactions
Pregnancy & Lactation
- Pregnancy category
- Excretion in breast milk
Use in Special Populations
- Elderly patients dosage recommendation
- Children dosage recommendation
- Renal and hepatic dysfunction dosage recommendation
Overdose Effects
- No known antidote
- Management with supportive care
Therapeutic Class
- Anti-emetic drugs
Storage Conditions
- Storage instructions